Target intelligence / Profile preview

Caseinolytic mitochondrial matrix peptidase proteolytic subunit (ClpP)

Target
ClpP
Molecular classification
Enzyme, Peptidase S14 family, Serine protease
01

Overview

ClpP (Caseinolytic mitochondrial matrix peptidase proteolytic subunit) is a highly conserved serine protease found in bacteria, mitochondria of eukaryotes, and some chloroplasts. In humans, it is encoded by the *CLPP* gene and plays a critical role in protein quality control by degrading misfolded or damaged proteins within the mitochondrial matrix. It functions as part of larger ATP-dependent proteolytic complexes such as ClpXP or ClpAP. In bacteria, it's critical for stress response, virulence regulation, cell cycle progression, and adaptation to environmental changes. In humans, mutations in *CLPP* are associated with Perrault syndrome type 3 (PRLTS3). It has emerged as an anti-cancer target because its activation can induce selective cancer cell death via disruption of mitochondrial function and bacterial ClpPs are targets for novel antibiotics.

Other names
PRLTS3DFNB81
02

Mechanism of action

Activation of ClpP induces cancer cell death via disruption of mitochondrial function; inhibition of bacterial ClpP disrupts bacterial pathogenicity.

03

Biological functions

Protein degradationProtein homeostasisMitochondrial functionStress responseVirulence regulationCell cycle progression
04

Disease associations

Perrault syndrome type 3 (PRLTS3)Sensorineural hearing lossOvarian dysfunctionCancerInfection

Beyond the preview

Go deeper on Caseinolytic mitochondrial matrix peptidase proteolytic subunit (ClpP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caseinolytic mitochondrial matrix peptidase proteolytic subunit (ClpP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call